(66 days)
The Visions® PV .035 Digital IVUS Catheter is designed for use in the evaluation of vascular morphology in blood vessels of the peripheral vasculature by providing a cross-sectional image of such vessels. This device is not currently indicated for use in cerebral vessels.
The Visions® PV .035 Digital IVUS Catheter is designed for use as an adjunct to conventional angiographic procedures to provide an image of the vessel lumen and wall structures and dimensional measurements from the image.
The Visions® PV .035 Digital IVUS Catheter is an over-the-wire intravascular imaging catheter with a digital ultrasound transducer at the distal end. The transducer utilizes a 64-element cylindrical array that radiates acoustic energy into the surrounding tissue and detects the subsequent echoes. The information from the echoes is used to generate real-time images of the peripheral vessels.
The Visions® PV .035 Digital IVUS Catheter is introduced percutaneously or via surgical cutdown into the vascular system, and is designed to track over 0.035"-0.038" (0.89-0.97mm) guide wires.
The catheter body has markers 1 cm apart along the working length. There are 25 radiopaque (RO) markers on the distal end of the catheter, starting 1 cm from the imaging plane, with the 25th RO marker overlapping the distal-most wide inked marker. Inked markers (non-radiopaque) continue along the shaft, spaced 1 cm apart, middle-to-middle, with wider marks indicating 5 cm intervals.
A lubricious hydrophilic coating is applied externally to a distal portion of the catheter. The Visions® PV .035 Digital IVUS Catheter, catalog number 88901, may only be used with the In-Vision Imaging System, Volcano s5" Series and CORE " Series of Systems. This catheter will not operate if connected to any other imaging system.
Based on the provided text, the device in question is the Volcano Visions® PV .035 Digital IVUS Catheter.
However, the document states that "Volcano Corporation made minor revisions to the instructions for use for the Visions® PV.035 Digital IVUS Catheter. These edits include revisions to contraindication section and other editorial changes to improve and streamline the overall IFU. There is no change to the current device design, specifications, indications, and/or any other characteristics."
Therefore, the provided document does not contain information about studies to prove acceptance criteria for a new device or a modified device with changes to design or specifications. Instead, it refers to a literature search conducted to support minor modifications to the contraindication sections, implying that the device's fundamental performance characteristics were already established by a previous submission (K121273 - the predicate device).
Given this, I cannot fully complete all sections of your request as the information is not present in the provided text. I will address the parts that can be inferred or explicitly stated.
1. A table of acceptance criteria and the reported device performance
The document explicitly states: "There is no change to the current device design, specifications, indications, and/or any other characteristics." This indicates that the performance criteria and reported performance remain the same as the predicate device (Visions® PV .035 Digital IVUS Catheter, K121273). The current submission focuses on minor revisions to the instructions for use, specifically contraindications. Therefore, no new performance data or acceptance criteria related to device function are presented.
| Acceptance Criteria | Reported Device Performance |
|---|---|
| Not specified in this document for device performance. This submission focuses on IFU revisions and refers to predicate device performance. | Not specified in this document for device performance. This submission focuses on IFU revisions and refers to predicate device performance. |
2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
Not applicable. No new test set data was generated or submitted for device performance as there were no changes to device design or specifications. A "literature search was carried out to support minor modifications to the contraindication sections," but details on sample size or provenance of that literature are not provided.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
Not applicable. No new test set requiring ground truth establishment was conducted for device performance. The literature search was used to evaluate contraindications, but details on expert involvement or qualifications are not given.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
Not applicable. No new test set requiring adjudication was conducted for device performance.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. The device is a diagnostic intravascular catheter, not an AI-assisted interpretation device. No MRMC studies or AI assistance are mentioned.
6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done
Not applicable. The device is a diagnostic intravascular catheter; it is used by a human operator and does not operate as a standalone algorithm for diagnosis.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)
Not applicable for device performance validation in this submission. The literature search supported modifications to contraindications, implying a review of existing medical knowledge, potentially including outcomes data or expert opinions from published studies, but this is not a "ground truth" for a new performance study.
8. The sample size for the training set
Not applicable. No new training set for an algorithm was used or described.
9. How the ground truth for the training set was established
Not applicable. No new training set for an algorithm was used or described.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the text "DEPARTMENT OF HEALTH & HUMAN SERVICES" in a bold, sans-serif font. The text is horizontally oriented and appears to be part of a document or heading. The words are capitalized, with each word separated by a space.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
December 31, 2015
Volcano Corporation Neeta Sharma Director, Regulatory Affairs 3721 Valley Centre Dr Ste 500 San Diego, CA 92130
Re: K153094
Trade/Device Name: Visions PV .035 Digital IVUS Catheter Regulation Number: 21 CFR 870.1200 Regulation Name: Diagnostic Intravascular Catheter Regulatory Class: Class II Product Code: OBJ Dated: December 11, 2015 Received: December 14, 2015
Dear Neeta Sharma:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in
{1}------------------------------------------------
the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerelv vours.
for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known) K153094
Device Name Visions® PV .035 Digital IVUS catheter
Indications for Use (Describe)
The Visions® PV .035 Digital IVUS Catheter is designed for use in the evaluation of vascular morphology in blood vessels of the peripheral vasculature by providing a cross-sectional image of such vessels. This device is not currently indicated for use in cerebral vessels.
The Visions® PV .035 Digital IVUS Catheter is designed for use as an adjunct to conventional angiographic procedures to provide an image of the vessel lumen and wall structures and dimensional measurements from the image.
| Type of Use (Select one or both, as applicable) |
|---|
| X Prescription Use (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
510(K) SUMMARY
| SPONSOR: | Volcano Corporation3721 Valley Center DriveSan Diego, CA 92130 |
|---|---|
| CONTACT/SUBMITTER: | Neeta SharmaDirector, Regulatory AffairsVolcano Corporation3721 Valley Center DriveSan Diego, CA 92130Tel: (858) 720-4187Fax: (858) 720-0335 |
| DATE PREPARED: | October 23, 2015 |
| DEVICE: | Volcano Visions® PV .035 Digital IVUS Catheter |
| TRADE NAME: | Visions® PV .035 Digital IVUS Catheter |
| COMMON NAME: | Diagnostic Intravascular Catheter |
| CLASSIFICATION: | 21 CFR 870.1200OBJ: Diagnostic Intravascular CatheterClass II Device |
| PREDICATE DEVICE: | Visions® PV .035 Digital IVUS Catheter, K121273 |
| DEVICE DESCRIPTION: | The Visions® PV .035 Digital IVUS Catheter is an over-the-wire intravascular imaging catheter with a digitalultrasound transducer at the distal end. The transducerutilizes a 64-element cylindrical array that radiates acousticenergy into the surrounding tissue and detects thesubsequent echoes. The information from the echoes is usedto generate real-time images of the peripheral vessels. |
| The Visions® PV .035 Digital IVUS Catheter is introducedpercutaneously or via surgical cutdown into the vascularsystem, and is designed to track over 0.035"-0.038" (0.89-0.97mm) guide wires. | |
| The catheter body has markers 1 cm apart along theworking length. There are 25 radiopaque (RO) markers onthe distal end of the catheter, starting 1 cm from theimaging plane, with the 25th RO marker overlapping thedistal-most wide inked marker. Inked markers (non- |
{4}------------------------------------------------
radiopaque) continue along the shaft, spaced 1 cm apart, middle-to-middle, with wider marks indicating 5 cm intervals.
A lubricious hydrophilic coating is applied externally to a distal portion of the catheter. The Visions® PV .035 Digital IVUS Catheter, catalog number 88901, may only be used with the In-Vision Imaging System, Volcano s5" Series and CORE " Series of Systems. This catheter will not operate if connected to any other imaging system.
INDICATIONS FOR USE:
The Visions® PV.035 Digital IVUS Catheter is designed for use in the evaluation of vascular morphology in blood vessels of the peripheral vasculature by providing a crosssectional image of such vessels. This device is not currently indicated for use in cerebral vessels.
The Visions® PV .035 Digital IVUS Catheter is designed for use as an adjunct to conventional angiographic procedures to provide an image of the vessel lumen and wall structures and dimensional measurements from the image.
COMPARISON OF CHARACTERISTICS:
Volcano Corporation made minor revisions to the instructions for use for the Visions® PV.035 Digital IVUS Catheter. These edits include revisions to contraindication section and other editorial changes to improve and streamline the overall IFU. There is no change to the current device design, specifications, indications, and/or any other characteristics.
PERFORMANCE DATA:
A literature search was carried out to support minor modifications to the contraindication sections for the Visions® PV.035 Digital IVUS Catheter. The results of this search supported modifications to the contraindication section.
§ 870.1200 Diagnostic intravascular catheter.
(a)
Identification. An intravascular diagnostic catheter is a device used to record intracardiac pressures, to sample blood, and to introduce substances into the heart and vessels. Included in this generic device are right-heart catheters, left-heart catheters, and angiographic catheters, among others.(b)
Classification. Class II (performance standards).